Archive for Medication updates
Class 3 Medicines Recall: Tricodent Limited (supplier), Medical Oxygen B.P (MEDIGAS OXYGEN B.P), EL (23)A/20
Source: MHRA/Gov.uk 6.6.23 The MHRA has been made aware that falsified medical oxygen has been provided to several dental practices across the UK. MDR number MDR 053-04/23 Company name Tricodent...
NEWS FLASH:Drug Supply Update-2nd June
Drug Supply Page Dispex provides primary care focused updates on drug supply issues. Data is taken from the SPS website on a weekly basis. Dispex members can login here to see the updated...
Serious Shortage Protocols VAT Update
Source: Serious Shortage Protocols/NHSBSA From 1 June 2023, the allowance for VAT currently paid alongside product reimbursement will stop being paid when reimbursing for products supplied in accordance with SSPs....
Concession Price Update 26th May 2023
Another 14 products have had their price increased. Click HERE to see the full list in alphabetical order. Click HERE to see the impact this has on Generics Costing More...
National Patient Safety Alert: Removal of Philips Health Systems V60 and V60 Plus ventilators from service: risk of shutdown leading to complete loss of ventilation (NatPSA/2023/005/MHRA)
Source: MHRA/Gov.uk 18.5.23 The MHRA is issuing updated advice that Philips Respironics V60 and V60 Plus non-invasive ventilators must be permanently removed from use. Date of issue: 18 May 2023...
Class 4 Medicines Defect Information: Novartis Pharmaceuticals, Simulect 10mg & 20mg powder and solvent for Solution for injection or infusion, EL (23)A/17
Source: MHRA / Gov.uk 16.5.23 Novartis Pharmaceuticals has informed the MHRA that the solvent (water for injections in ampoules) co-packed with the impacted batches of Simulect powder for injection, may...
Dispensing and the drive for environmental sustainability
Assessment of Long-Acting Beta Agonists (LABAs) We continue our journey to transform Respiratory care to the lowest possible carbon impact by looking at LABAs this month. Chlorofluorocarbons (CFCs) inhaler propellants...
Class 3 Medicines Recall: Hikma Farmacêutica Portugal S.A., Gemcitabine 1g/26.3ml & 2g/52.6ml Solution For Infusion Vial, EL(23)A/16
Source: MHRA /Gov.uk 10th May 2023 Hikma Farmacêutica Portugal S.A has informed the MHRA of a potential issue impacting the batches listed in this notification. MDR number MDR 002-05/23 Company...
National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Emerade 500 micrograms and Emerade 300 micrograms auto-injectors, due to the potential for device failure, NatPSA/2023/004/MHRA
Source: MHRA / Gov.uk Pharmaswiss Česka republika s.r.o. is initiating an urgent recall of all batches of Emerade 500 micrograms and Emerade 300 micrograms auto-injectors. National Patient Safety Alert Reference...
NEWS FLASH:Drug Supply Update-5th May
Drug Supply Page Dispex provides primary care focused updates on drug supply issues. Data is taken from the SPS website on a weekly basis. Dispex members can login here to see the updated...
NEWS FLASH: Drug Tariff Update April 2023
We have updated our Drug Tariff page…………. ADDITIONS TO APRIL 2023 DRUG TARIFF DELETIONS FROM APRIL 2023 DRUG TARIFF ADDITIONS TO PART VIIIA EFFECTIVE FROM 1 MAY 2023 DELETIONS FROM...
Class 4 Medicines Defect Information: Omega Pharma Ltd, Beconase Hayfever Nasal Spray, EL (23)A/15
Source: MHRA / Gov.uk 26.4.23 Omega Pharma Ltd has identified that there is text missing in Section 2 of the Patient Information Leaflet (PIL) in packs of Beconase Hayfever Nasal...
